FDA Opens Public Docket for Pediatric Sodium Nitroprusside Studies

Summary

The FDA is making available a report on pediatric studies of sodium nitroprusside conducted in accordance with the Public Health Service Act, as submitted to the NIH Director and FDA Commissioner.